Results 161 to 170 of about 27,657 (216)

Clinical and health economic impact of isavuconazole for treatment of invasive aspergillosis and mucormycosis: a retrospective, matched multicentre cohort study in Germany. [PDF]

Infection
Engelhard M, Wingen-Heimann SM, Grüner B, Vehreschild MJGT, Kessel J, Ehrlich S, Spiekermann K, Schalk E, Baermann BN, Vehreschild JJ, Pütz SM.   +10 more
europepmc   +1 more source

Case Report: Rare invasive aspergillosis with brain abscess in a non-classically immunosuppressed patient, and pooled analysis of individual patient data (2000-2024). [PDF]

Front Surg
Regmi M, Liu S, Dai Y, Ye J, Chen X, Yang J, Yang C.   +6 more
europepmc   +1 more source

Pseudomembranous Aspergillus tracheobronchitis: A Rare Manifestation of Invasive Aspergillosis in a Immunocompetent Patient. [PDF]

Infect Drug Resist
Xu XQ, Ye CX, Li N, Yu X, Liao YF, Shen Y.   +5 more
europepmc   +1 more source

Invasive aspergillosis

, 2020
openaire   +1 more source

Phase 2, open-label, noncomparative clinical trial evaluating safety and efficacy of posaconazole in pediatric patients with proven/probable invasive aspergillosis or possible invasive fungal disease. [PDF]

Antimicrob Agents Chemother
Kang HJ, Arrieta AC, Dhooge C, Kelemen Á, Macías-Parra M, Aranda L, Dinikina YV, Kassis I, Cesaro S, Shepherd A, Shah AK, Mackey T, Waskin H, Johnson MG.   +13 more
europepmc   +1 more source

Real-World Experience with Isavuconazole for Invasive Aspergillosis in Hematologic Patients with and Without COVID-19 in Brazil. [PDF]

J Fungi (Basel)
Gandolpho LS, Ponzio V, Batista MV, França E Silva ILA, Ramos JF, Nucci M, Colombo AL.   +6 more
europepmc   +1 more source

Massive hemoptysis due to pulmonary artery pseudoaneurysm in invasive aspergillosis in a patient with interstitial lung disease and suspected Aspergillioma: A case report. [PDF]

Respir Med Case Rep
Ranjan N, Ishak A, Cherabuddi M, Garrett S, Sheth R, Wadhwa A, Diaz Mendoza JI.   +6 more
europepmc   +1 more source